<DOC>
	<DOCNO>NCT01767337</DOCNO>
	<brief_summary>This study evaluate intracutaneous delivery 0.1 , 0.25 0.5 milliliter volume saline FLUGEN 101.2 investigational microneedle-based device .</brief_summary>
	<brief_title>Intracutaneous Delivery Varied Dose Volumes Saline</brief_title>
	<detailed_description />
	<criteria>Able read and/or understand sign Informed Consent form Medical history acute chronic skin disease Active skin allergy acute skin infection , presence tattoo ( ) , scar , sunburn skin abnormality prospective injection site Hirsute prospective injection site Diabetes High level anxiety depression history psychosis Abuse alcohol use drug abuse include tobacco Pregnant breastfeed woman Any medical condition may interfere study protocol adherence include completion study activity Foreseeable inability complete study schedule .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>microneedle-based delivery</keyword>
	<keyword>hollow microneedle</keyword>
	<keyword>intracutaneous</keyword>
	<keyword>drug delivery</keyword>
</DOC>